Feline immunodeficiency virus env gene evolution in experimentally infected cats

被引:17
作者
Kraase, Martin [1 ]
Sloan, Richard [1 ]
Klein, Dieter [2 ,3 ]
Logan, Nicola [1 ]
McMonagle, Linda [1 ]
Biek, Roman [4 ]
Willett, Brian J. [1 ]
Hosie, Margaret J. [1 ]
机构
[1] Univ Glasgow, Fac Vet Med, Inst Comparat Med, Retrovirus Res Lab, Glasgow G61 1QH, Lanark, Scotland
[2] Univ Vet Med Vienna, Dept Pathobiol, Inst Virol, A-1210 Vienna, Austria
[3] Univ Vet Med Vienna, Vetom Core Facil Res, A-1210 Vienna, Austria
[4] Univ Glasgow, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland
基金
英国生物技术与生命科学研究理事会;
关键词
FIV; Evolution; Lentivirus; IN-VIVO RECOMBINATION; ENVELOPE GLYCOPROTEIN; FUNCTIONAL RECEPTOR; NEUTRALIZATION; CD134; CELLS; HIV-1; SENSITIVITY; POSITION; TROPISM;
D O I
10.1016/j.vetimm.2009.10.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Feline immunodeficiency virus (FIV), an immunosuppressive lentivirus found in cats worldwide, is studied to illuminate mechanisms of lentiviral pathogenesis and to identify key components of protective immunity. During replication, lentiviruses accumulate errors of nucleotide mis-incorporation due to the low-fidelity of reverse transcriptase and recombination between viral variants, resulting in the emergence of a complex viral "quasispecies". In patients infected with HIV-1, env sequences may vary by up to 10% and the detection of quasispecies with greater heterogeneity is associated with higher viral loads and reduced CD4+T cell numbers [1], indicating that transmission of more complex quasispecies may lead to disease progression. However, little is known about how FIV evolves as disease progresses, or why some cats develop AIDS rapidly while disease progression is slow in others. The aim of this study was to determine whether disease progression may be governed by viral evolution and to examine the diversity of viral variants emerging following infection with an infectious molecular clone. The FIV env gene encoding the envelope glycoprotein (Env) was examined at early (12 weeks) and late (322 weeks) stages of FIV infection in two groups of cats infected experimentally with the FIV-GL8 molecular clone. Viral variants were detected within quasispecies in cats in the late stages of FIV infection that contained differing amino acid compositions in several variable loops of Env, some of which were identified as determinants of receptor usage and resistance to neutralization. Therefore these results indicate that the FIV env gene evolves during the course of infection, giving rise to variants that resist neutralization and likely lead to disease progression. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:96 / 106
页数:11
相关论文
共 60 条
[1]   IMMUNOLOGICAL ABNORMALITIES IN PATHOGEN-FREE CATS EXPERIMENTALLY INFECTED WITH FELINE IMMUNODEFICIENCY VIRUS [J].
ACKLEY, CD ;
YAMAMOTO, JK ;
LEVY, N ;
PEDERSEN, NC ;
COOPER, MD .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5652-5655
[2]   During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein [J].
Bendinelli, M ;
Pistello, M ;
del Mauro, D ;
Cammarota, G ;
Maggi, F ;
Leonildi, A ;
Giannecchini, S ;
Bergamini, C ;
Matteucci, D .
JOURNAL OF VIROLOGY, 2001, 75 (10) :4584-4593
[3]   CLINICAL AND PATHOLOGICAL FINDINGS IN FELINE IMMUNODEFICIENCY VIRUS EXPERIMENTAL-INFECTION [J].
CALLANAN, JJ ;
THOMPSON, H ;
TOTH, SR ;
ONEIL, B ;
LAWRENCE, CE ;
WILLETT, B ;
JARRETT, O .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 35 (1-2) :3-13
[4]   Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections [J].
Callanan, JJ ;
Jones, BA ;
Irvine, J ;
Willett, BJ ;
McCandlish, IAP ;
Jarrett, O .
VETERINARY PATHOLOGY, 1996, 33 (03) :264-272
[5]  
Cammarota G, 1996, AIDS RES HUM RETROV, V12, P173, DOI 10.1089/aid.1996.12.173
[6]   Change in coreceptor use correlates with disease progression in HIV-1-infected individuals [J].
Connor, RI ;
Sheridan, KE ;
Ceradini, D ;
Choe, S ;
Landau, NR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) :621-628
[7]   Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor [J].
de Parseval, A ;
Chatterji, U ;
Sun, PQ ;
Elder, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) :13044-13049
[8]   Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: Role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor [J].
de Parseval, A ;
Elder, JH .
JOURNAL OF VIROLOGY, 2001, 75 (10) :4528-4539
[9]   Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node [J].
Dean, GA ;
Reubel, GH ;
Moore, PF ;
Pedersen, NC .
JOURNAL OF VIROLOGY, 1996, 70 (08) :5165-5169
[10]   Slower evolution of human immunodeficiency virus type I quasispecies during progression to AIDS [J].
Delwart, EL ;
Pan, H ;
Sheppard, HW ;
Wolpert, D ;
Neumann, AU ;
Korber, B ;
Mullins, JI .
JOURNAL OF VIROLOGY, 1997, 71 (10) :7498-7508